We would love to hear your thoughts about our site and services, please take our survey here.
An RNS any day up to Monday 8th ? https://www.aacr.org/meeting/aacr-annual-meeting-2024/schedule-at-a-glance/
Agreed Rob. Thanks Berm and as said by C11, tidying up. Scancell pulling it all together IMO. GL
Thanks Balerno for your 10.20 and Moonparty for the reprise re. iSCIB1+
And Asco just around the corner - happy days . . . .
Dracula - you are as mysterious yet transparent as ever. And BTW, why would anyone sell to keep the price down?
NO chance AT ALL of a cheap buyout. As Konar posted at 16.10, "There is no way someone buys up a controlling stake on the open market without driving the price through the roof."
Vulpes and Redmile fully know what they have here with their ample shareholdings and IMO, they'll not be divesting 'cheap'. As EE pointed out, any offer would have to be at "a price that is attractive for them (or) there will be no bid".
Filtered.
Reminds me of a song, "you've got to, accentuate the negative, ignore the positive". Dooh - well done Scancell and Royal Preston Hospital!!
Don't mess with Mr In-between . . .
Why whinge about that Rich ??
Great news - I don't care when I get it, as long as I do . . .
Well done team Scancell !
Re. your last post, make that at least 2 persons Chester !
And this in Bermuda's reply to you, hoping that - " top line results for stage 2 of the SCIB1 study are as good as stage 1", am I correct in remembering that Prof. Lindy said that the chances of that were around 90%? (I'm hoping I haven't pulled that quote from another context?).
IMO too, it's fair to expect news in the coming weeks ! GLA
Yes Drac. So when "good news IS out there we would be seeing It In a very progressive SP movement" or words to that effect. A SCOPE update seems likely in the next few weeks. Thanks for the positive view.
Johnny thanks for the MM perspective.
Hadley - please, what program? What time ? Thanks.
BioNTech had a good ride with Covid vax . . . let's hope, for their sake, they haven't 'peaked'. Do they need to get out of their 'tunnel' in which case, some Scancell assets might be useful for them?
Violin - your 11.06 had been fairly answered by both Bermuda and Johnny, who are certainly as likely to be as right, as anyone else. Did you miss their posts?
The other day you posted that the SP will fall even when good news arrives - I thought that an interesting mindset, akin to legendary negativity.
No one will be snapping this up for 50p IMHO. TCOY . ATB
Hi Barbel. I see that's your first post for 6 months or so. Glad to see you still 'keep the faith'. You've been holding for many years? ATB
BOJO thanks for your 09.13 and Ray for 11.15 and 11.35 giving us a really helpful and clear explanation of Avidimab - a good refresher for oldies and an essential for newbies.
So come on Genmab and all !!
Cleaner/WTP/Drac - thanks for those cheering thoughts for the weekend. It's fair to suggest the possibility of wider Genmab interest, after all, their toe is already in the water.
That's not to forget Merck, BMS, Pfizer, Moderna and others. Though I have long expected BioNTech to 'frontrun' with interest in Scancell because of their longstanding familiarity, I wonder if their thrust into science is stuck in their own no doubt brilliant tunnel.
We'll see. But if data from Immunobody and Moditope platforms continues to be strong, Scancell are sure to be 'hot property' in due course, as the case against personalised vaccines goes under the spotlight.
I won't be selling more than a few for 50 pence, that's for sure.
All being well . . . . .
WTP - re. "we continue to build SIGNIFICANT momentum" - that's a very strong comment. Thanks for highlighting it. But IMO, 'nothing between the lines.
Sath appointed on 29/8 has now as expected, been made a Director. At the AGM etc. I thought Sath showed composure and charm and I feel Scancell are in very good hands, on this front too.
In fact, the whole Scancell team is looking as good as it needs to be.
Now for data . . . . tick tock . . . . . . .
Konar - maybe no coincidence. KF is still flying high and I'm sure if it was needed, his input would certainly have been helpful.
When we start trialing in the USA, it'll be good to have KF onside and maybe he might yet be involved in running the trial ?
IMO it's great that Prof. Lindy this AACR, is making an address !
Mia that's a nice reminder.
Johnny re-posted Scancell's words, yesterday 11.12 - "Presentations at these high-profile conferences follow the significant recent progress that Scancell has made in both pre-clinical and clinical development" MMmmm
Scancell are undeniably banging the drum currently and sowing the seeds - let's hope we get more insights/encouragement or maybe a real data update at the AACR. IMO important to note that Prof. Lindy is making a formal presentation at this massive event. GLA
'My' Chantaburi on the East of the Gulf is normally prosperous with gemstones, durian and fishing but hasn't recovered from the pandemic - it's the poor that feel it. Laem Sing on the coast nearby is still very quiet except at weekends.
The far south Andaman island, Ko Lipe is lovely - my Missis is there atm with a couple of Friends, catching the sleeper train back tonight. I took the chance to catch up with old Friends in Korat, which is also very quiet (expat wise).
Yes Bojo - it's a reflex by now !
But PNP and HH are a 'strong buy' too. GN
EE - I'd guess PNP would generally be a quiet place particularly midweek but a little busier with Thai visitors Sat/Sun. Years ago we ate at a first floor Restaurant by the harbourside.
Yes a change since Covid as some seem to have lost the habit of going out and many places are quiet or closed down. Outside hotspots the economy is probably reduced.
If you can, spend some time in Hua Hin up the road, which by repute is pleasant and more lively.